Olivier Cerles

ORCID: 0000-0001-5697-7484 · 3 papers in corpus
article 2017
Free radical biology & medicine ·doi:10.1016/j.freeradbiomed.2017.04.362

The redox-sensitive nuclear factor erythroid-derived 2-like 2 (NRF2) controls endogenous antioxidant enzymes' transcription and protects against oxidative damage which is triggered by inflammation and known to favor progression of endometri…

article 2015
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719115592708

IntroductionSorafenib is a strong multikinase inhibitor targeting 2 different pathways of endometriosis pathogenesis: RAF kinase and vascular endothelial growth factor receptor (VEGFR). We investigate whether Sorafenib could control the gro…

review 2015
Expert opinion on therapeutic targets ·doi:10.1517/14728222.2015.1090974

INTRODUCTION: The pathogenesis of endometriosis, a common benign disease, remains ill-defined, although it is clear that chronic inflammation plays a crucial role through mitogen-activated protein kinase (MAPK) signaling pathways. All curre…